Basic HTML Version
The device:
Orsiro Hybrid Drug Eluting Stent
•
PROBIO® passive coating encapsulates the stent and minimizes
interaction between the metal stent and the surrounding tissue
•
BIOlute® active coating contains a highly biocompatible polymer
which delivers a Limus drug via a biodegradable matrix
•
PRO-Kinetic Energy Stent System brings good deliverability for
reaching complex lesions
BIOlute® achieves a
controlled drug release
The BIOlute® polymer matrix
gently degrades into CO
2
and H
2
O
Only a PROBIO® sealed stent
is left in the arterial wall
Quick facts
Passive coating
PROBIO® amorphous silicon carbide coating
Active coating
BIOlute® bioabsorbable PLLA eluting Sirolimus
Drug dose
1.4 µg/mm
2
Stent material
Cobalt chromium L-605
Strut thickness
60 µm (3.00 mm stent)
Approval status
CE approved